HOWARU® B420®
Image credits: © IFF, Finland, 2021 (FESEM imaging VTT)
The primary health attributes of HOWARU® Bifidobacterium lactis B420® are weight management and metabolic health, which may be related to its ability to support intestinal barrier integrity.¹⁻³ In addition, Akkermansia muciniphila, a bacterial species linked to lean healthy body weight, was increased in abundance in the intestine upon B420® supplementation.⁴
- 90 scientific publications
- 30+ clinical trial publications
Metabolic
B420® CLINICAL STUDIES & PUBLICATIONS
B. lactis B420® has been documented in more than 90 scientific publications, including more than 30 clinical trial publications. It has been demonstrated in clinical trials to survive intestinal passage, and in vitro studies have shown excellent adhesion to human colonic mucus.⁸⁻¹⁰
Health Benefit Areas
Each strain’s health benefits are supported by recommended daily doses and peer-reviewed clinical studies.
Click on a Health Benefit to see more studies and learn more.
Supporting Daily Dose: 10B CFU B420®
Study Reference:
References: 1. Lindfors K et al.; Clin Exp Immunol. 2008; 2. Putaala H at al.; Res Microbiol. 2008; 3. Mokkala K et al.; Nutr Res. 2016; 4. Hibberd AA et al.; Beneficial Microbes. 2018; 5. Stenman LK et al.; EBioMedicine. 2016; 6. Stenman LK et al.; Diabetology & Metabolic Syndrome. 2015; 7. Stenman LK et al.; Beneficial Microbes. 2014; 8. Klein A et al.; Eur J Clin Nutr. 2008; 9. Kok RG et al.; Appl Environ Microbiol. 1996; 10. Collado MC et al.;Lett Appl Microbiol. 2007.